Journal of Thermal Analysis and Calorimetry

, Volume 130, Issue 1, pp 413–423 | Cite as

Thermal properties of iopamidol

Crystalline anhydrous, hydrated and amorphous forms
  • Barbara Bellich
  • Federica Bertolotti
  • Silvia Di Fonzo
  • Elena Elisei
  • Alessandro Maiocchi
  • Fulvio Uggeri
  • Norberto Masciocchi
  • Attilio CesàroEmail author


Three crystal forms of iopamidol, an iodinated contrast media used in radiology, have been so far elucidated: an anhydrous, a monohydrate and a pentahydrate form (labeled hereafter as W0, W1 and W5, respectively), which showed the occurrence of different conformations, atropisomeric in nature. Specifically, the anhydrous and monohydrate forms contain iopamidol with a “syn” conformation of the two symmetric sidearms, while an “anti” conformation was found in the pentahydrate, making it a conformational (pseudo)-polymorph of the first two. The three crystal forms have been here investigated by means of DSC, variable temperature X-ray powder diffraction and Raman spectroscopy. This study enabled us to highlight the thermal-induced transformations, leading to the discovery of new crystal forms, for a total of four hydrated and four distinct anhydrous phases. In particular, the DSC curve of W0 revealed only a reversible solid–solid transition at around 180 °C before melting, with subsequent degradation above 300 °C. W1, after the loss of lattice water around 100 °C, shows a characteristic split peak at about 250 °C, which is attributed to melting. Below 150 °C, powder diffraction of W1 suffers of minor changes, with a smooth variation of the lattice parameters, in agreement with a progressive loss of water in a reversible event, monitored also by DSC. At variance, W5 evidenced an irreversible loss of water in three distinct steps, for three, one and one H2O molecules each, respectively; subsequent transitions occur at 140 and 180 °C, before melting at 240 °C. Three clearly visible transformations were also detected by variable temperature powder diffraction measurements, where the loss of three molecules of water in a single step, generating a bis-hydrated species (W2), is followed by a second dehydration process leading, above 75 °C, to a new monohydrate phase W1′, different from the known W1 form. The Raman spectra of the three crystal forms, measured upon heating up to 160 °C, evidenced changes in spectral regions of amides that, according to our simulations of the vibrational properties, can be attributed to changes of the hydration properties and, more significantly, in terms of the “syn” and “anti” conformations.


Iopamidol solid state DSC XRD Raman 



Research carried out in the framework of a collaboration between the University of Trieste and the Bracco Research Center under the Project “Physical Chemistry of Iodinated Contrast Media.” G. Giannini is acknowledged for some preliminary calorimetric measurements. Partial financial support to F.B. by Federchimica (Milan, Italy) and support for computational work by CINECA ISCRA grants (Bologna, Italy) is gratefully acknowledged.


  1. 1.
    Krause W, Schneider PW. Chemistry of X-ray contrast agents. In: Krause W, editor. Contrast agents II: optice, ultrasound, X-ray and radiopharmaceutical imaging. Topics in current chemistry. Berlin: Springer; 2002. p. 107–50.Google Scholar
  2. 2.
    Bonnemain B, Meyer D, Schaefer M, Dugast-Zrihen M, Legreneur S, Doucet D. New iodinated low-osmolar contrast media: a revised concept of hydrophilicity. Invest Radiol. 1990;25:S104–6.CrossRefGoogle Scholar
  3. 3.
    Krasuski RA, Sketch MH, Harrison JK. Contrast agents for cardiac angiography: osmolality and contrast complications. Curr Interv Cardiol Rep. 2000;2:258–66.CrossRefGoogle Scholar
  4. 4.
    Bonati F, Felder E, Tirone P. Iopamidol: new preclinical and clinical data. Invest Radiol. 1980;15:S310–6.CrossRefGoogle Scholar
  5. 5.
    Drayer BP, Warner MA, Sudilovsky A, Luther J, Wilkins R, Allen S, et al. Iopamidol vs metrizamide: a double blind study for cervical myelography. Neuroradiology. 1982;24:77–84.CrossRefGoogle Scholar
  6. 6.
    Felder E, Grandi M, Pitrè D, Vittadini G. Iopamidol. In: Florey K, editor. Analytical profiles of drug substances, vol. 17. San Diego: Academic Press; 1988. p. 115–54.Google Scholar
  7. 7.
    Ganazzoli F, Albinati A, Pitrè D. Iopamidol, C17H22I3N3O8. Acta Crystallogr C. 1983;39:1570–2.CrossRefGoogle Scholar
  8. 8.
    Bellich B, Di Fonzo S, Tavagnacco L, Paolantoni M, Masciovecchio C, Bertolotti F, Giannini G, De Zorzi R, Geremia S, Maiocchi A, Uggeri F, Masciocchi N, Cesàro A. Myelography iodinated contrast media. II. Conformational versatility of iopamidol in the solid state. Mol Pharm. 2017;14:468–77.CrossRefGoogle Scholar
  9. 9.
    Fontanive L, D’Amelio N, Cesàro A, Gamini A, Tavagnacco L, Paolantoni M, Brady JW, Maiocchi A, Uggeri F. Myelography iodinated contrast media. I. Unraveling the atropisomerism properties in solution. Mol Pharm. 2015;12:1939–50.CrossRefGoogle Scholar
  10. 10.
    Giron D. Investigations of polymorphism and pseudo-polymorphism in pharmaceuticals by combined thermoanalytical techniques. J Therm Anal Calorim. 2001;64:37–60.CrossRefGoogle Scholar
  11. 11.
    Kawakami K. Reversibility of enantiotropically related polymorphic transformations from a practical viewpoint: thermal analysis of kinetically reversible/irreversible polymorphic transformations. J Pharm Sci. 2007;96:982–9.CrossRefGoogle Scholar
  12. 12.
    Malpezzi L, Fuganti C, Maccaroni E, Masciocchi N, Nardi A. Thermal and structural characterization of two polymorphs of Atovaquone and of its chloro derivative. J Therm Anal Calorim. 2010;102:203–10.CrossRefGoogle Scholar
  13. 13.
    Terada K, Kurobe H, Ito M, Yoshihashi Y, Yonemochi E, Fujii K, Uekusa H. Polymorphic and pseudomorphic transformation behavior of acyclovir based on thermodynamics and crystallography. J Therm Anal Calorim. 2013;113:1261–7.CrossRefGoogle Scholar
  14. 14.
    Faroongsarng D. Theoretical aspects of differential scanning calorimetry as a tool for the studies of equilibrium thermodynamics in pharmaceutical solid phase transitions. AAPS PharmSciTech. 2016;17:1–6.CrossRefGoogle Scholar
  15. 15.
    Brandel C, Amharar Y, Rollinger JM, Griesser UJ, Cartigny Y, Petit S, Coquerel G. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers. Mol Pharm. 2013;10:3850–61.CrossRefGoogle Scholar
  16. 16.
    Coquerel G, Tamura R. Enantiomeric disorder pharmaceutically oriented. In: Descamps M, editor. Disordered pharmaceutical materials. Weinheim: Wiley-VCH; 2016. p. 135–59.CrossRefGoogle Scholar
  17. 17.
    Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14:33–8.CrossRefGoogle Scholar
  18. 18.
    Willart JF, Descamps M. Solid state amorphization of pharmaceuticals. Mol Pharm. 2008;5:905–20.CrossRefGoogle Scholar
  19. 19.
    TOPAS-R, V. 3.0, Bruker AXS, 2005, Karlsruhe, Germany.Google Scholar
  20. 20.
    Cheary RW, Coelho A. A fundamental parameters approach to X-ray line-profile fitting. J Appl Cryst. 1992;25:109–21.CrossRefGoogle Scholar
  21. 21.
    D’Amico F, Saito M, Bencivenga F, Marsi M, Gessini A, Camisasca G, Principi E, Cucini R, Di Fonzo S, Battistoni A, Giangrisostomi E, Masciovecchio C. UV Resonant Raman Scattering Facility at Elettra. Nucl Instrum Methods Phys Res A. 2013;703:33–7.CrossRefGoogle Scholar
  22. 22.
    Sussich F, Skopec C, Brady JW, Cesàro A. Reversible dehydration of trehalose and anhydrobiosis: from solution state to an exotic crystal? Carbohydr Res. 2001;334:165–76.CrossRefGoogle Scholar
  23. 23.
    Furuki T, Kishi A, Sakurai M. De-and rehydration behavior of α,α-trehalose dihydrate under humidity-controlled atmospheres. Carbohydr Res. 2005;340:429–38.CrossRefGoogle Scholar
  24. 24.
    Pina MF, Pinto JF, Sousa JJ, Fábián L, Zhao M, Craig DQ. Identification and characterization of stoichiometric and nonstoichiometric hydrate forms of paroxetine HCl: reversible changes in crystal dimensions as a function of water absorption. Mol Pharm. 2012;9:3515–25.CrossRefGoogle Scholar
  25. 25.
    Tangeman JA, Lange RA. Determination of the limiting fictive temperature of silicate glasses from calorimetric and dilatometric methods: application to low-temperature liquid volume measurements. Am Mineral. 2001;86:1331–44.CrossRefGoogle Scholar
  26. 26.
    Dollish FG, Fately WG, Bentley FF. Characteristic Raman frequencies of organic compounds. New York: Wiley; 1974.Google Scholar
  27. 27.
    Das D, Jacobs T, Barbour LJ. Exceptionally large positive and negative anisotropic thermal expansion of an organic crystalline material. Nat Mater. 2010;9:36–9.CrossRefGoogle Scholar
  28. 28.
    Vippagunta SR, Brittain HG, Grant DJ. Crystalline solids. Adv Drug Deliv Rev. 2001;48:3–26.CrossRefGoogle Scholar

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2017

Authors and Affiliations

  1. 1.Laboratory of Physical and Macromolecular Chemistry, Department of Chemical and Pharmaceutical SciencesUniversity of TriesteTriesteItaly
  2. 2.Department of Science and High Technology and To.Sca.LabUniversity of InsubriaComoItaly
  3. 3.Elettra Sincrotrone TriesteArea Science ParkTriesteItaly
  4. 4.Bracco Imaging SpACentro Ricerche BraccoColleretto GiacosaItaly

Personalised recommendations